Table of Contents 1 Market Overview 1.1 Opioid-Induced Constipation Introduction 1.2 Market Analysis by Type 1.2.1 Solid 1.2.2 Liquid 1.3 Market Analysis by Applications 1.3.1 Drugstore 1.3.2 Hospital 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 AstraZeneca 2.1.1 Business Overview 2.1.2 Opioid-Induced Constipation Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Takeda Pharmaceutical 2.2.1 Business Overview 2.2.2 Opioid-Induced Constipation Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Valeant Pharmaceuticals International 2.3.1 Business Overview 2.3.2 Opioid-Induced Constipation Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Abbott 2.4.1 Business Overview 2.4.2 Opioid-Induced Constipation Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Bayer 2.5.1 Business Overview 2.5.2 Opioid-Induced Constipation Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Boehringer Ingelheim 2.6.1 Business Overview 2.6.2 Opioid-Induced Constipation Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 C.B. Fleet 2.7.1 Business Overview 2.7.2 Opioid-Induced Constipation Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Cosmo Pharmaceuticals 2.8.1 Business Overview 2.8.2 Opioid-Induced Constipation Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Daewoong 2.9.1 Business Overview 2.9.2 Opioid-Induced Constipation Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Daiichi Sankyo 2.10.1 Business Overview 2.10.2 Opioid-Induced Constipation Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 GlaxoSmithKline 2.11.1 Business Overview 2.11.2 Opioid-Induced Constipation Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Ironwood Pharmaceuticals 2.12.1 Business Overview 2.12.2 Opioid-Induced Constipation Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Johnson & Johnson 2.13.1 Business Overview 2.13.2 Opioid-Induced Constipation Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Johnson & Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Merck 2.14.1 Business Overview 2.14.2 Opioid-Induced Constipation Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Mundipharma 2.15.1 Business Overview 2.15.2 Opioid-Induced Constipation Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 Nektar Therapeutics 2.16.1 Business Overview 2.16.2 Opioid-Induced Constipation Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 Pfizer 2.17.1 Business Overview 2.17.2 Opioid-Induced Constipation Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.18 Progenics Pharmaceuticals 2.18.1 Business Overview 2.18.2 Opioid-Induced Constipation Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.19 Shionogi 2.19.1 Business Overview 2.19.2 Opioid-Induced Constipation Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.20 SLA Pharma 2.20.1 Business Overview 2.20.2 Opioid-Induced Constipation Type and Applications 2.20.2.1 Product A 2.20.2.2 Product B 2.20.3 SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.21 Sucampo 2.21.1 Business Overview 2.2.2 Opioid-Induced Constipation Type and Applications 2.21.2.1 Product A 2.21.2.2 Product B 2.21.3 Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.22 Synergy Pharmaceuticals 2.22.1 Business Overview 2.22.2 Opioid-Induced Constipation Type and Applications 2.22.2.1 Product A 2.22.2.2 Product B 2.22.3 Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.23 Theravance 2.23.1 Business Overview 2.23.2 Opioid-Induced Constipation Type and Applications 2.23.2.1 Product A 2.23.2.2 Product B 2.23.3 Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Opioid-Induced Constipation Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Opioid-Induced Constipation Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Opioid-Induced Constipation Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Opioid-Induced Constipation Manufacturer Market Share in 2017 3.3.2 Top 6 Opioid-Induced Constipation Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Opioid-Induced Constipation Market Analysis by Regions 4.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Regions 4.1.1 Global Opioid-Induced Constipation Sales and Market Share by Regions (2013-2018) 4.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Regions (2013-2018) 4.2 North America Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 4.3 Europe Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 4.5 South America Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 5 North America Opioid-Induced Constipation by Countries 5.1 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries 5.1.1 North America Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018) 5.1.2 North America Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018) 5.2 United States Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 5.3 Canada Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 5.4 Mexico Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 6 Europe Opioid-Induced Constipation by Countries 6.1 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Countries 6.1.1 Europe Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018) 6.2 Germany Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 6.3 UK Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 6.4 France Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 6.5 Russia Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 6.6 Italy Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 7 Asia-Pacific Opioid-Induced Constipation by Countries 7.1 Asia-Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018) 7.2 China Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 7.3 Japan Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 7.4 Korea Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 7.5 India Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 8 South America Opioid-Induced Constipation by Countries 8.1 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries 8.1.1 South America Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018) 8.1.2 South America Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 8.3 Argentina Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 8.4 Colombia Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 9 Middle East and Africa Opioid-Induced Constipation by Countries 9.1 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 9.3 UAE Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 9.4 Egypt Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 9.5 Nigeria Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 9.6 South Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018) 10 Global Opioid-Induced Constipation Market Segment by Type 10.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Opioid-Induced Constipation Sales and Market Share by Type (2013-2018) 10.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2013-2018) 10.2 Solid Sales Growth and Price 10.2.1 Global Solid Sales Growth (2013-2018) 10.2.2 Global Solid Price (2013-2018) 10.3 Liquid Sales Growth and Price 10.3.1 Global Liquid Sales Growth (2013-2018) 10.3.2 Global Liquid Price (2013-2018) 11 Global Opioid-Induced Constipation Market Segment by Application 11.1 Global Opioid-Induced Constipation Sales Market Share by Application (2013-2018) 11.2 Drugstore Sales Growth (2013-2018) 11.3 Hospital Sales Growth (2013-2018) 11.4 Others Sales Growth (2013-2018) 12 Opioid-Induced Constipation Market Forecast (2018-2023) 12.1 Global Opioid-Induced Constipation Sales, Revenue and Growth Rate (2018-2023) 12.2 Opioid-Induced Constipation Market Forecast by Regions (2018-2023) 12.2.1 North America Opioid-Induced Constipation Market Forecast (2018-2023) 12.2.2 Europe Opioid-Induced Constipation Market Forecast (2018-2023) 12.2.3 Asia-Pacific Opioid-Induced Constipation Market Forecast (2018-2023) 12.2.4 South America Opioid-Induced Constipation Market Forecast (2018-2023) 12.2.5 Middle East and Africa Opioid-Induced Constipation Market Forecast (2018-2023) 12.3 Opioid-Induced Constipation Market Forecast by Type (2018-2023) 12.3.1 Global Opioid-Induced Constipation Sales Forecast by Type (2018-2023) 12.3.2 Global Opioid-Induced Constipation Market Share Forecast by Type (2018-2023) 12.4 Opioid-Induced Constipation Market Forecast by Application (2018-2023) 12.4.1 Global Opioid-Induced Constipation Sales Forecast by Application (2018-2023) 12.4.2 Global Opioid-Induced Constipation Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Opioid-Induced Constipation Picture Table Product Specifications of Opioid-Induced Constipation Figure Global Sales Market Share of Opioid-Induced Constipation by Types in 2017 Table Opioid-Induced Constipation Types for Major Manufacturers Figure Solid Picture Figure Liquid Picture Figure Opioid-Induced Constipation Sales Market Share by Applications in 2017 Figure Drugstore Picture Figure Hospital Picture Figure Others Picture Figure United States Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Canada Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Germany Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure France Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure UK Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Russia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Italy Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure China Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Japan Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Korea Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure India Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Opioid-Induced Constipation Type and Applications Table AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Takeda Pharmaceutical Opioid-Induced Constipation Type and Applications Table Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base and Competitors Table Valeant Pharmaceuticals International Opioid-Induced Constipation Type and Applications Table Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Abbott Basic Information, Manufacturing Base and Competitors Table Abbott Opioid-Induced Constipation Type and Applications Table Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bayer Basic Information, Manufacturing Base and Competitors Table Bayer Opioid-Induced Constipation Type and Applications Table Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors Table Boehringer Ingelheim Opioid-Induced Constipation Type and Applications Table Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table C.B. Fleet Basic Information, Manufacturing Base and Competitors Table C.B. Fleet Opioid-Induced Constipation Type and Applications Table C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Cosmo Pharmaceuticals Opioid-Induced Constipation Type and Applications Table Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Daewoong Basic Information, Manufacturing Base and Competitors Table Daewoong Opioid-Induced Constipation Type and Applications Table Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors Table Daiichi Sankyo Opioid-Induced Constipation Type and Applications Table Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Opioid-Induced Constipation Type and Applications Table GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Ironwood Pharmaceuticals Opioid-Induced Constipation Type and Applications Table Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Opioid-Induced Constipation Type and Applications Table Johnson & Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Opioid-Induced Constipation Type and Applications Table Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Mundipharma Basic Information, Manufacturing Base and Competitors Table Mundipharma Opioid-Induced Constipation Type and Applications Table Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Nektar Therapeutics Basic Information, Manufacturing Base and Competitors Table Nektar Therapeutics Opioid-Induced Constipation Type and Applications Table Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Opioid-Induced Constipation Type and Applications Table Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Progenics Pharmaceuticals Opioid-Induced Constipation Type and Applications Table Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Shionogi Basic Information, Manufacturing Base and Competitors Table Shionogi Opioid-Induced Constipation Type and Applications Table Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table SLA Pharma Basic Information, Manufacturing Base and Competitors Table SLA Pharma Opioid-Induced Constipation Type and Applications Table SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sucampo Basic Information, Manufacturing Base and Competitors Table Sucampo Opioid-Induced Constipation Type and Applications Table Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Synergy Pharmaceuticals Opioid-Induced Constipation Type and Applications Table Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Theravance Basic Information, Manufacturing Base and Competitors Table Theravance Opioid-Induced Constipation Type and Applications Table Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Opioid-Induced Constipation Sales by Manufacturer (2016-2017) Figure Global Opioid-Induced Constipation Sales Market Share by Manufacturer in 2016 Figure Global Opioid-Induced Constipation Sales Market Share by Manufacturer in 2017 Table Global Opioid-Induced Constipation Revenue by Manufacturer (2016-2017) Figure Global Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2016 Figure Global Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2017 Figure Top 3 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2017 Figure Global Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Global Opioid-Induced Constipation Revenue and Growth Rate (2013-2018) Table Global Opioid-Induced Constipation Sales by Regions (2013-2018) Table Global Opioid-Induced Constipation Sales Market Share by Regions (2013-2018) Table Global Opioid-Induced Constipation Revenue by Regions (2013-2018) Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2013 Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2017 Figure North America Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Europe Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure South America Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure North America Opioid-Induced Constipation Revenue and Growth Rate (2013-2018) Table North America Opioid-Induced Constipation Sales by Countries (2013-2018) Table North America Opioid-Induced Constipation Sales Market Share by Countries (2013-2018) Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2013 Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2017 Table North America Opioid-Induced Constipation Revenue by Countries (2013-2018) Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018) Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2013 Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2017 Figure United States Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Canada Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Mexico Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Europe Opioid-Induced Constipation Revenue and Growth Rate (2013-2018) Table Europe Opioid-Induced Constipation Sales by Countries (2013-2018) Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2013-2018) Table Europe Opioid-Induced Constipation Revenue by Countries (2013-2018) Figure Europe Opioid-Induced Constipation Revenue Market Share by Countries in 2016 Figure Europe Opioid-Induced Constipation Revenue Market Share by Countries in 2017 Figure Germany Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure UK Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure France Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Russia Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Italy Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Asia-Pacific Opioid-Induced Constipation Revenue and Growth Rate (2013-2018) Table Asia-Pacific Opioid-Induced Constipation Sales by Countries (2013-2018) Table Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries 2017 Table Asia-Pacific Opioid-Induced Constipation Revenue by Countries (2013-2018) Figure Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Countries 2017 Figure China Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Japan Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Korea Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure India Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure South America Opioid-Induced Constipation Revenue and Growth Rate (2013-2018) Table South America Opioid-Induced Constipation Sales by Countries (2013-2018) Table South America Opioid-Induced Constipation Sales Market Share by Countries (2013-2018) Figure South America Opioid-Induced Constipation Sales Market Share by Countries in 2017 Table South America Opioid-Induced Constipation Revenue by Countries (2013-2018) Table South America Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018) Figure South America Opioid-Induced Constipation Revenue Market Share by Countries in 2017 Figure Brazil Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Argentina Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Colombia Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Middle East and Africa Opioid-Induced Constipation Revenue and Growth Rate (2013-2018) Table Middle East and Africa Opioid-Induced Constipation Sales by Countries (2013-2018) Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries in 2017 Table Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2013-2018) Table Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries in 2013 Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries in 2017 Figure Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure UAE Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Egypt Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure Nigeria Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Figure South Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018) Table Global Opioid-Induced Constipation Sales by Type (2013-2018) Table Global Opioid-Induced Constipation Sales Share by Type (2013-2018) Table Global Opioid-Induced Constipation Revenue by Type (2013-2018) Table Global Opioid-Induced Constipation Revenue Share by Type (2013-2018) Figure Global Solid Sales Growth (2013-2018) Figure Global Solid Price (2013-2018) Figure Global Liquid Sales Growth (2013-2018) Figure Global Liquid Price (2013-2018) Table Global Opioid-Induced Constipation Sales by Application (2013-2018) Table Global Opioid-Induced Constipation Sales Share by Application (2013-2018) Figure Global Hospital Sales Growth (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Opioid-Induced Constipation Sales, Revenue and Growth Rate (2018-2023) Table Global Opioid-Induced Constipation Sales Forecast by Regions (2018-2023) Table Global Opioid-Induced Constipation Market Share Forecast by Regions (2018-2023) Figure North America Sales Opioid-Induced Constipation Market Forecast (2018-2023) Figure Europe Sales Opioid-Induced Constipation Market Forecast (2018-2023) Figure Asia-Pacific Sales Opioid-Induced Constipation Market Forecast (2018-2023) Figure South America Sales Opioid-Induced Constipation Market Forecast (2018-2023) Figure Middle East and Africa Sales Opioid-Induced Constipation Market Forecast (2018-2023) Table Global Opioid-Induced Constipation Sales Forecast by Type (2018-2023) Table Global Opioid-Induced Constipation Market Share Forecast by Type (2018-2023) Table Global Opioid-Induced Constipation Sales Forecast by Application (2018-2023) Table Global Opioid-Induced Constipation Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

AstraZeneca Takeda Pharmaceutical Valeant Pharmaceuticals International Abbott Bayer Boehringer Ingelheim C.B. Fleet Cosmo Pharmaceuticals Daewoong Daiichi Sankyo GlaxoSmithKline Ironwood Pharmaceuticals Johnson & Johnson Merck Mundipharma Nektar Therapeutics Pfizer Progenics Pharmaceuticals Shionogi SLA Pharma Sucampo Synergy Pharmaceuticals Theravance